Signaling Pathways - F1 Fo-ATPase - PD-1/PD-L1 interaction - Myosin light chain kinases (MLCKs) - Cyclin-Dependent Kinases
清除全部
- B6023 PD-1/PD-L1 inhibitor 2Target: PD-1/PD-L1 interactionSummary: PD-1/PD-L1相互作用的抑制剂
- A8717 THZ21 CitationTarget: Cyclin-Dependent KinasesSummary: CDK7抑制剂
- A8736 THZ531Target: Cyclin-Dependent KinasesSummary: CDK12 和CDK13共价抑制剂
- A8885 Ro 33064 CitationTarget: Cyclin-Dependent KinasesSummary: CDK1抑制剂
- B4754 LDC0000672 CitationTarget: Cyclin-Dependent KinasesSummary: 高特异性的CDK9抑制剂
- B6935 Aminopurvalanol ATarget: Cyclin-Dependent KinasesSummary: 细胞周期蛋白依赖性激酶抑制剂
- B6342 H-7 dihydrochlorideTarget: PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: 蛋白激酶抑制剂
- B4736 THZ1 HydrochlorideTarget: Cyclin-Dependent KinasesSummary: CDK7抑制剂
- B3672 Indirubin中文名: 靛玉红Target: Cyclin-Dependent Kinases|GSK-3Summary: 细胞周期蛋白依赖性激酶和GSK-3β抑制剂
- B3523 Fasudil中文名: 法舒地尔Target: ROCK|PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: 钙拮抗剂